Advertisement

Topics

Latest "Demegen Incorporated" News Stories

12:07 EST 13th December 2017 | BioPortfolio

Here are the most relevant search results for "Demegen Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Demegen Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Demegen Incorporated for you to read. Along with our medical data and news we also list Demegen Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Demegen Incorporated Companies for you to search.

Showing "Demegen Incorporated" News Articles 1–25 of 40

Thursday 7th December 2017

Novartis tender offer for Advanced Accelerator Applications commences

Novartis International AG / Novartis tender offer for Advanced Accelerator Applications commences . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Basel, December 7, 2017 -Novartis AG (NYSE: NVS) ("Novartis") today announced that its direct and indirect subsidiary, Novartis Groupe France S...


Monday 4th December 2017

Resverlogix Closes Previously Announced $87 Million Private Placement with Shenzhen Hepalink

CALGARY, Alberta, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has closed its previously announced private placement of 60,416,667 equity units to Shenzhen Hepalink Pharmaceutical Co. Ltd. ("Hepalink") at a price of $1.44 per unit for gross proceeds of $87 million. Each unit was comprised ...

Friday 1st December 2017

Copley Scientific to showcase new TPK™ 2100 Critical Flow Controller for dry powder inhaler testing at DDL2017

A highly automated system to speed up testing, improve reproducibility, and enhance data output and recording Monday 27th November: Nottingham, UK: Copley Scientific, the world’s leading manufacturer of inhaler test equipment, will be presenting its new 3rd generation Critical Flow Controller – the TPK™ 2100 – for the testing of dry powder inhalers (DPIs) at the 2017 Dr...


Copley Scientific introduces new, upgraded breath simulators for inhaled product testing.

13th November 2017: Nottingham, UK: Copley Scientific, the world’s leading manufacturer of inhaler test equipment, launches new advanced breath simulators, the BRS 2100 and BRS 3100, for orally inhaled product (OIP) development and testing. In recent years, in response to regulatory and pharmacopoeial changes, and the drive to ensure closer correlation between in vivo and in vitro performa...

Thursday 30th November 2017

U.S. FDA Grants Shire Orphan Drug Designation for Investigational Anti-MAdCAM Antibody SHP647 for the Treatment of Moderately to Severely Active Ulcerative Colitis in Pediatric Patients

U.S. FDA Grants Shire Orphan Drug Designation for Investigational Anti-MAdCAM Antibody SHP647 for the Treatment of Moderately to Severely Active Ulcerative Colitis in Pediatric Patients Cambridge, Ma.  - November 30, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), the world's leading biotechnology company in rare diseases, today announced that the U.S. Food and Drug Administra...

Monday 27th November 2017

Milestone Scientific's CompuFlo(R) Epidural System, Wand(R) STA Dental System and Cosmetic Instrument Featured in Television Broadcasts and in Premier Online News Journal

LIVINGSTON, NJ--(Marketwired - November 28, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Wand® STA Dental and CompuFlo® Epidural systems were featured in separate television news broadcasts in Pittsburgh and South Florida, respectively....

Thursday 16th November 2017

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it priced its offering of $500.0 million aggregate principal amount of 4.625% senior notes due 2027 (the “Notes”) at an issue price of 100.000%. The sale of the Notes is expected to close on November 20, 2017, subject to customary closing conditions. The Notes will be guar...

Teleflex Incorporated Announces Public Offering of $500 Million of Senior Notes

Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today the registered public offering, subject to market and other conditions, of $500.0 million aggregate principal amount of senior notes due 2027 (the “Notes”). The interest rate and other terms of the Notes will be determined at pricing. The Notes will be guaranteed by each of Tel...

Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction

Molecular Health GmbH / Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Cambridge, MA, USA - November 16, 2017 -  Molecular Health, Inc (MH), a company marketing computational biomedicine...

Friday 10th November 2017

Shire presentations at ASH 2017 highlight commitment to furthering research and innovation in Hematology and Oncology

Shire presentations at ASH 2017 highlight commitment to furthering research and innovation in Hematology and Oncology Lexington, Mass. - November 10, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving people with rare diseases, today announced the broad range of research it will present at the 59th American Society of Hematology (ASH) A...

Thursday 9th November 2017

Ligand Reports Third Quarter 2017 Financial Results

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and nine months ended September 30, 2017, and provided an operating forecast and program updates. “Ligand’s diversified business is performing well on all levels. In the third quarter, we posted strong financial results driven by royalties and sig...

Wednesday 8th November 2017

Dynavax Announces FDA Approval of HEPLISAV-B(TM) for Prevention of Hepatitis B in Adults

BERKELEY, CA--(Marketwired - November 09, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. HEPLISAV-B is the first new hepatitis B vaccine in t...

Tuesday 7th November 2017

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock equivalents at a price to the public of $1.75 per share.  H.C. Wainwright & Co., LLC is acting as the sole book-running manager for the offering. The gross proceeds from this offering are exp...

Mannatech Reports Third Quarter 2017 Financial Results

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2017. Third Quarter Results Third quarter net

Thursday 2nd November 2017

Dynavax Reports Third Quarter 2017 Financial Results

BERKELEY, CA--(Marketwired - November 03, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the third quarter ended September 30, 2017. Cash, cash equivalents and marketable securities were $191.7 million at September 30, 2017 compared to $81.4 million at December 31, 2016. The increase was primarily due to net proceeds of approximately $169 million duri...

Hydropothecary releases versatile Decarb Micro THC and Decarb Micro CBD medical marijuana powders at $3 per gram

GATINEAU, QC--(Marketwired - November 03, 2017) - The Hydropothecary Corporation ("Hydropothecary" or the "Company") (TSX VENTURE: THCX) is pleased to announce the release of two new products, Decarb Micro THC and Decarb Micro CBD. Part of the Company's unique innovative line of Decarb products, Decarb Micro THC and Decarb Micro CBD are ready-to-consume, activated medical marijuana powders. Deca...

Teleflex Reports Third Quarter 2017 Results

Third Quarter Revenues of $534.7 million, up 17.4% Versus Prior Year Period; up 15.4% on Constant Currency Basis Third Quarter GAAP Diluted EPS of $1.70, up 21.4% Over Prior Year Period Third Quarter Adjusted Diluted EPS of $2.12, up 17.8% Versus Prior Year Period Raised 2017 Guidance Range for GAAP Revenue Growth from a R...

Wednesday 18th October 2017

Dynavax Initiates Clinical Trial in Non-Small Cell Lung Cancer with a Novel Inhaled TLR9 Agonist in Combination with Anti-PD-1 Therapy

BERKELEY, CA--(Marketwired - October 19, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced initiation of dosing in a phase 1B dose escalation clinical trial of its investigational inhaled toll-like receptor 9 (TLR9) agonist, DV281, in patients with non-small cell lung cancer (NSCLC). This multi-center, open label trial is designed to evaluate safety and identify the optimal dose f...

Thursday 5th October 2017

Pharmacovigilance Database E2B(R3) Compliance: A Technical and Practical Perspective

TORONTO, ON--(Marketwired - October 06, 2017) - In a complimentary webinar taking place on Thursday, October 26, 2016 at 11am EDT (4pm BST) industry experts Tom Nichols, Senior Director of Pharmacovigilance at Quanticate and Dr. Marc Zittartz, Chief Quality Officer at Pharmasol will address a major step forward in the pharmaceutical industry from both a technical perspective as well as the day-to...

Wednesday 4th October 2017

Angle PLC: Results of Fundraising

GUILDFORD, SURREY -- (Marketwired) -- 10/05/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY) (AIM:AGL OTCQX:ANPCY) THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR ANY...

Tuesday 3rd October 2017

Advanced Bifurcation Systems Announces Plan for Human Clinical Trials in New Brunswick, Canada

LOS ANGELES, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Advanced Bifurcation Systems ("ABS" or the "Company"), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties, today announced that the Company is planning to undertake human cl...

Monday 2nd October 2017

Teleflex Incorporated Completes Acquisition of NeoTract

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies designed to improve the health and quality of people’s lives, announced today the completion of its previously announced acquisition of NeoTract, Inc. On September 5, 2017, the two companies announced a definitive agreement for Teleflex to acquire NeoTract in a ...

Monday 18th September 2017

MetLife Hong Kong Expands Coverage for People with Diabetes and Introduces Insurtech Solution

HONG KONG, CHINA -- (Marketwired) -- 09/19/17 -- MetLife Hong Kong* announced today that it has extended the scope of its "MetLife Health-is-Wealth Medical Plan" to include people living with diabetes, and offered its customers insurtech solutions for proactive health management. For the 1 in 10 people in Hong Kong living with diabetes, finding insurance cover that provides comprehensive coverage...

Herbalife Announces Amendment and Extension of Its Tender Offer for Common Shares

Herbalife Ltd. (NYSE: HLF) (“Herbalife”) announced today it is amending its previously announced cash tender offer in order to clarify or expand upon certain disclosures in response to comments from the Securities and Exchange Commission (“SEC”), including providing more detail regarding contingent value rights (each, a “CVR”), which make up a part of...

Wednesday 13th September 2017

Milestone Scientific Announces Children's Hospital of Pittsburgh to use The Wand(R) Computer Assisted Anesthesia System for Pediatric Patients

LIVINGSTON, NJ --(Marketwired - September 14, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a medical company that develops and commercializes a growing portfolio of proprietary injection technologies, today announced that the Children's Hospital of Pittsburgh will now utilize The Wand® computer assisted anesthesia system for its pediatric patients. In addition, The Wa...


Quick Search
Advertisement
 

News Quicklinks